Skip to main content

Pulse Biosciences, Inc.

PLSE
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001625101

In the last 90 days, Pulse Biosciences, Inc. insiders filed 2 open-market purchases and 0 sales; 105 institutions reported holding it in 13F filings for Q2 2026, worth $297.0M in total; no superinvestor holds it.

Q1 2022 vs. Q4 2021

How the institutions holding Pulse Biosciences, Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022All holders in Q4 2021

13F holders of PLSE: Q4 2021 compared with Q1 2022
MeasureQ4 2021Q1 2022Change
Holders4855+7
Shares4.07M4.22M+151.1K (+3.7%)
Value$60.3M$20.5M−$39.8M (−66.0%)

New holders (12)

Institutions that held Pulse Biosciences, Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to PLSE in Q1 2022
InstitutionSharesValue% of portfolio
D. E. Shaw & Co., Inc.101,016$491.0K0.00%
Renaissance Technologies LLC77,824$378.0K0.00%
Two Sigma Investments, LP59,636$290.0K0.00%
Marshall Wace, LLP25,575$124.0K0.00%
Cubist Systematic Strategies, LLC19,186$93.0K0.00%
Occudo Quantitative Strategies LP18,402$89.0K0.01%
Amalgamated Bank2,273$11.0K0.00%
Amalgamated Financial Corp.2,273$11.0K0.00%
FMR LLC1,297$6.00K0.00%
Group One Trading, L.P.661$3.00K0.00%
Massmutual Trust Co FSB111$1.00K0.00%
Point72 Hong Kong Ltd273$1.00K0.00%

Sold out (5)

Institutions that held Pulse Biosciences, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.

Institutions that sold out of PLSE in Q1 2022
InstitutionShares, Q4 2021Value, Q4 2021
Granahan Investment Management Inc435,160$6.45M
Tiaa, FSB27,298$404.0K
Gsa Capital Partners LLP11,102$164.0K
US Bancorp79$1.00K
The PNC Financial Services Group, Inc.34$1.00K